Chairs
Current Chair: Neha Patel
Chair-elect candidate: Dania Alhamad
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update
March 30, 2026
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by:…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics
March 30, 2026
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics…
New Meds and Tech: DESMODA™ (desmopressin acetate) Oral Solution
March 24, 2026
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution …